Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01588951 · FLOW

Participant flow

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior · Source last updated 2018-08-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Without LSC, standard cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.
    id
    FG000
    title
    No Leukemia Stem Cells - Consolidation
  2. description
    LSC present, randomized to cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.
    id
    FG001
    title
    Leukemia Stem Cells - Consolidation
  3. description
    LSC present, randomized to allogeneic transplant Allogeneic transplant: Allogeneic stem cell transplant per institutional standards.
    id
    FG002
    title
    Leukemia Stem Cells - Transplant
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Ineligible in retrospect
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        6
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        5
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Without LSC, standard cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.
    id
    FG000
    title
    No Leukemia Stem Cells - Consolidation
  2. description
    LSC present, randomized to cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.
    id
    FG001
    title
    Leukemia Stem Cells - Consolidation
  3. description
    LSC present, randomized to allogeneic transplant Allogeneic transplant: Allogeneic stem cell transplant per institutional standards.
    id
    FG002
    title
    Leukemia Stem Cells - Transplant
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Ineligible in retrospect
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        6
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        5
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice